Pharmaceuticals
Moonwalk Biosciences Announces $70 Million Series B: NYSE Content Update
NYSE issues a pre-market daily advisory direct from the trading floor. NEW YORK, Sept. 9, 2026 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begin...
2026-09-09 20:56
6384
Kazia Therapeutics Announces First Patient Dosed in PNOC035 Clinical Study Evaluating Paxalisib for Recurrent Pediatric AT/RT Brain Cancer
Multicenter study to evaluate paxalisib plus gemcitabine for children and young
adults with recurrent or progressive AT/RT, where no approved therapies
currently exist
SYDNEY, Sept. 9, 2026 /PRNewswire/ -- Kazia Therapeutics Limited
2026-09-09 19:30
2070
ZAGENO Earns Frost & Sullivan's 2026 North American Life Sciences E‑Commerce Company of the Year Recognition
Honored for transforming life sciences procurement through digital innovation,
automation, and a customer-first platform
SAN ANTONIO, Sept. 9, 2026 /PRNewswire/ -- Frost & Sullivan
2026-09-09 04:00
2190
Alebund Pharmaceuticals Announces FDA Clearance of IND Application for AP308 for the Treatment of IgA Nephropathy
SHANGHAI, Sept. 8, 2026 /PRNewswire/ -- Alebund Pharmaceuticals (Jiangsu) Limited ("Alebund" or the "Company"; HKEX: 09637), a renal-focused biopharmaceutical company, today announced that it has recently received clearance from the U.S. Food and Drug Administration (FDA) of its Investigational ...
2026-09-08 20:15
1693
Kelun-Biotech's Partner Windward Bio Announces Positive Phase 2 Results of SKB378/WIN378 in Asthma, and Initiates Phase 3 Study
* The POLARIS-1 study enrolled 147 patients with uncontrolled, moderate-to-severe asthma, and the interim analysis was conducted on the first 98 patients. The analysis demonstrated a half-life of up to 75 days, with clinical effects consistent with twice-yearly dosing. * SKB378/WIN378 produce...
2026-09-08 20:02
1915
Ascletis Announces Initiation of Phase I Study in U.S. for Oral Amylin Receptor Peptide Agonist ASC36 for the Treatment of Obesity
- This trial marks the fourth Phase I peptide study for Ascletis this year. - ASC36 oral tablets achieved absolute oral bioavailability of 6% to 8% at steady state in non-human primate (NHP) studies utilizing Ascletis' proprietary Peptide Oral Transport ENhancement Technology (POTENT). - ASC36 o...
2026-09-08 18:10
2023
PeproMene Bio Announces Publication in The Lancet of Breakthrough Phase 1 Clinical Trial Results Demonstrating Deep and Durable Complete Responses in Relapsed/Refractory B-cell Lymphomas, including after prior CD19 CAR T-cell failure
IRVINE, Calif., Sept. 8, 2026 /PRNewswire/ -- PeproMene Bio, Inc. today
announced the publication inThe Lancet
2026-09-08 18:01
1923
PT Prodia Diacro Laboratories Receives Frost & Sullivan's 2026 Southeast Asian Contract Research Organization Customer Value Leadership Recognition for Customer-Centric Clinical Research Excellence
Prodia the CRO is recognized for its reliable, integrated clinical research
ecosystem, customer-centric delivery model, and commitment to quality,
innovation, and long-term sponsor value across Southeast Asia.
SAN ANTONIO, Sept. 8, 2026 /PRNewswire/ -- Frost & Sullivan
2026-09-08 13:00
1354
/C O R R E C T I O N -- Wooree Group/
In the news release, Wooree Group Concludes Vitafoods Asia 2026, CEO Ji-yong Yoon Calls for Scientific Validation Standard for Liposome Claims, issued 07-Sep-2026 by Wooree Group over PR Newswire, we are advised by the company that the product name "Harutin" should read "Haroutine" throughout the...
2026-09-08 12:06
4710
Taiwan's HORIEN Accelerates Global Footprint: Achieves Three Thai FDA Class 4 Approvals and Secures U.S. Patent for Biodegradable Ureteral Stent
Market-entry initiative targets qualified Thai distributors across dental, surgical, wound-care, and regenerative medicine channels, while solidifying global IP leadership in advanced urological biomaterials. TAICHUNG, Sept. 8, 2026 /PRNewswire/ -- HORIEN Biochemical Technology Co., Ltd. (TPEx: ...
2026-09-08 10:00
3272
Ascletis Announces Inclusion in the Hong Kong Stock Connect List under the Shanghai-Hong Kong Stock Connect and the Shenzhen-Hong Kong Stock Connect Programs
HONG KONG, Sept. 7, 2026 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") announces that, the ordinary shares of the Company (the "Shares"), which trade on The Stock Exchange of Hong Kong Limited (the "HK Stock Exchange"), have been included in the list of eligible securities under t...
2026-09-07 12:15
2838
Ddrops® Brings Medical Experts from Damansara Specialist Hospital and Motherhood.com.my Together in Malaysia for Science-Backed Vitamin D Forum
KUALA LUMPUR, Malaysia, Sept. 7, 2026 /PRNewswire/ -- Ddrops®
2026-09-07 12:00
2870
CART Blood Pressure Monitor Demonstrates Utility in BP Monitoring for AF and Heart Failure Patients
- First to demonstrate clinical utility of ring-type BP monitoring in AF and heart failure patients - Highlighted CART blood pressure monitor's multifaceted value, including ESH-based validation and sleep apnea tracking MUNICH and SEOUL, South Korea, Sept. 7, 2026 /PRNewswire/ -- Sky Labs (CEO J...
2026-09-07 08:00
1829
AtomVie Global Radiopharma Celebrates the Grand Opening of its New State-of-the-Art Radiopharmaceutical Manufacturing Facility in Hamilton, Ontario
HAMILTON, ON, Sept. 5, 2026 /PRNewswire/ - AtomVie Global Radiopharma (AtomVie), a leading global Contract Development and Manufacturing Organization (CDMO) in the radiopharmaceutical industry, today celebrated the Grand Opening of its new purpose-built, state-of-the-art manufacturing facility at...
2026-09-05 00:29
3890
DIMERIX SECURES A$34 MILLION NON-DILUTIVE FACILITY TO FUND KEY CLINICAL MILESTONES
* Dimerix successfully enters into non-dilutive facility agreements to access A$34 million[1] with a syndicate of Australian and U.S. independent lenders, including the previously announced initial facility of A$10 million[2] * Facility terms for all Lenders substantially consistent with the p...
2026-09-04 11:00
3938
TraceLink and Omnicell Integrate DSCSA Compliance Solution into Hospital Pharmacy Operations
Integration brings serialized product verification and traceability directly into medication receiving workflows, intended to enable more efficient pharmacy operations without separate compliance processes. BOSTON, Sept. 3, 2026 /PRNewswire/ -- TraceLink, the world's largest Agentic Business Net...
2026-09-03 22:00
2658
ClinHope Officially Establishes Hong Kong Branch to Strengthen Asia-Pacific Market Presence
TAIPEI, Sept. 3, 2026 /PRNewswire/ -- ClinHope today announced the official establishment of its Hong Kong branch. Following its operations in Taiwan and the United States, this marks another step in expanding into the Asian market and deepening its global service footprint. As the biotech, phar...
2026-09-03 16:09
2073
Everest Medicines Announces China NMPA Approval of CARDAMYST® for the Conversion of Acute Symptomatic Episodes of Paroxysmal Supraventricular Tachycardia (PSVT) to Sinus Rhythm in Adults
SHANGHAI, Sept. 3, 2026 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and commercialization of innovative therapeutics, today announced that China's National Medical Product...
2026-09-03 13:20
2695
The Galien Foundation Announces the Nominees for the Inaugural 2026 Prix Galien Korea Awards
Historic First Edition Launches in Partnership with MK Media (Maekyung), Yozma Group Korea, the Korea Pharmaceutical and Bio-Pharma Manufacturers Association (KPBMA), and KoreaBIO at the World Knowledge Forum in Seoul SEOUL, South Korea, Sept. 3, 2026 /PRNewswire/ -- The Galien Foundation, the p...
2026-09-03 08:00
2354
EpiVax Launches AI-Enhanced Models for Immunogenicity Prediction
PROVIDENCE, R.I., Sept. 3, 2026 /PRNewswire/ -- EpiVax, Inc. is pleased to
announce the release of AI-enabled enhancements toISPRI™
2026-09-02 23:19
1939
Week's Top Stories
Most Reposted
CityUHK and University of Cambridge establish Centre for Advanced and Smart Manufacturing to shape Hong Kong's Industry 5.0 future
[Picked up by 291 media titles]
2026-09-22 18:37
Agoda Releases AI Developer Report 2026: Agentic AI Adoption Outpaces Enterprise Readiness Across Southeast Asia and India
[Picked up by 291 media titles]
2026-09-24 10:30
CGS International Convenes China-ASEAN Business Leaders Summit to Deepen Capital Connectivity Across the Corridor
[Picked up by 278 media titles]
2026-09-23 09:00
01F Group Announces Investment in DANA, Indonesia's Leading Digital Financial Company, Reinforcing Long-Term Confidence in Asia's Fintech Opportunity
[Picked up by 275 media titles]
2026-09-21 08:00Malaysia Calls for Shift from Halal-Certified to Halal-Competitive as ASEAN Targets USD5 Trillion Global Halal Economy
[Picked up by 274 media titles]
2026-09-25 14:45
Most Read
The Sanya EDITION Presents an Island Celebration Experience for Mid-Autumn Festival and China National Day Golden Week
2026-09-19 09:00
7370
iScreen Expands iOS 27 Customization With New Extra-Large Widget Experiences, iPhone Duo Theme Support and AI-Powered Home Screen Design
2026-09-19 06:00
7339
